Odds of invasive mechanical ventilation, death significantly increased for those with RSV versus vaccinated COVID, flu
Risk Profile IDs COVID-19 Patients Who Will Benefit From Baricitinib
Baricitinib plus remdesivir linked to reduced risk of death, progression to invasive mechanical ventilation
Maternal COVID-19 Vaccination May Reduce Neonatal Respiratory Distress
The odds of neonatal respiratory distress were higher for unvaccinated mothers versus those vaccinated before infection
Prone Positioning Does Not Cut Time to Weaning in ARDS With VV-ECMO
Early application of prone positioning during ECMO not associated with shorter time to successful weaning
Plasma From Convalescent Donors Beneficial for COVID-19-Induced ARDS
Plasma with neutralizing antibody titer of at least 1:160 reduces mortality at 28 days versus standard care
Transient Decrease in Pediatric Bronchiolitis Hospitalizations Seen During Pandemic
Hospitalizations decreased during 2020 to 2021 season, then increased in 2022 to 2023 season for pediatric patients
Range of Long-Term Symptoms Seen After SARS-CoV-2, Non-COVID-19 ARI
Researchers find increased prevalence/severity of most symptoms and reduced health-related quality of life
Pediatric RSV Hospitalizations Increased in 2021 to 2022 Season
Severity of illness remained similar to prepandemic seasons
Most Seniors With RSV-Linked Hospitalization Are Aged ≥75
And patients aged ≥60 years hospitalized with RSV are more likely to have severe illness than those with COVID-19, influenza
Some Immunosuppressed Do Not Have Anti-Spike Antibodies After COVID-19 Vaccination
IgG anti-spike antibodies undetectable in ~20 percent with immunosuppression who had received three or more COVID-19 vaccines